0001161697-23-000200.txt : 20230330
0001161697-23-000200.hdr.sgml : 20230330
20230330170051
ACCESSION NUMBER: 0001161697-23-000200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230328
FILED AS OF DATE: 20230330
DATE AS OF CHANGE: 20230330
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANDE ALICIA
CENTRAL INDEX KEY: 0001402652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 23781537
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 03-28-2023
X0407
4
2023-03-28
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402652
GRANDE ALICIA
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
VP, Treasurer and CFO
0
Common stock, par value $0.001 per share
2023-03-28
4
M
0
58216
0.79
A
108773
D
Common stock, par value $0.001 per share
2023-03-28
4
S
0
28216
16.60
D
80557
D
Common stock, par value $0.001 per share
2023-03-28
4
S
0
10000
16.55
D
70557
D
Common stock, par value $0.001 per share
2023-03-28
4
S
0
10000
16.52
D
60557
D
Common stock, par value $0.001 per share
2023-03-28
4
S
0
10000
16.37
D
50557
D
Common stock, par value $0.001 per share
2023-03-29
4
M
0
50000
1.13
A
100557
D
Common stock, par value $0.001 per share
2023-03-29
4
S
0
20000
16.72
D
80557
D
Common stock, par value $0.001 per share
2023-03-29
4
S
0
20000
16.70
D
60557
D
Common stock, par value $0.001 per share
2023-03-29
4
S
0
10000
16.67
D
50557
D
Options to purchase common stock
0.79
2023-03-28
4
M
0
58216
0
D
2023-06-15
Common Stock
58216
1345834
D
Options to purchase common stock
1.13
2023-03-29
4
M
0
50000
0
D
2024-01-03
Common Stock
50000
1295834
D
Shares were sold to cover exercise price of options, tax withholding requirements and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.
Options vested in two annual tranches beginning on June 15, 2017.
Options vested in three annual tranches beginning on January 3, 2018.
/s/ Alicia Grande
2023-03-30